Precision Imaging to Evaluate Kaposi Sarcoma

Study acronym: PRIME-KS
StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Enrollment reduced 40% 300 → 180 participants
See other at-risk trials from Washington University School of Medicine

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment reduced: 300 → 180 participants
    • Eligibility criteria expanded, about 13 words
    • Publications: details revised at 1 of 1 entry
  2. Re-verified, no change to tracked fieldsv8
  3. Recruitment opened
    • Start date changed from estimate of May 31, 2026 to Apr 10, 2026
    • Site details revised at 2 of 2 sites
    v7
  4. Re-verified, no change to tracked fieldsv6
  5. Enrollment target: 100 to 300v5
Show 3 earlier versionsHide 3 earlier versions
  1. Start date: Mar 28, 2025 to May 31, 2026
    • Trial status: Recruiting to Not Yet Recruiting
    • Site details revised at 2 of 2 sites
    v4
  2. Site details revised at 1 of 2 sitesv3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 1, 2025 to Mar 28, 2025
    • Site details revised at 2 of 2 sites
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
AIMS 2 \& 3: In this study the investigators seek to formally compare reproducibility and accuracy of KS lesion size measurements between SkinScan3D and the current standard of care manual measurement method. The investigators will then test the SS3D device on 100 patients in a variety of real-world practice locations to determine whether the device will be usable, acceptable, appropriate, and feasible in routine care settings.
Trial Details
NCT Number NCT06898203
Lead Sponsor Washington University School of Medicine
Collaborators: National Cancer Institute (NCI), Pensievision, Kenya Medical Research Institute, Makerere University
Conditions
(from sponsor)		 Kaposi Sarcoma
Related terms Sarcoma, Kaposi
Enrollment 180 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov